Shamburg News · 8-K filed Oct 16, 2026, 9:20 AM EDT
Sanara MedTech Receives FTC Second Request on Proposed Merger with MiMedx
SMTI · Sanara MedTech Inc.
- Acquisition
- Other event
- Reg FD disclosure
- Materiality: medium
On October 15, 2026, Sanara MedTech and MiMedx Group each received a Second Request from the Federal Trade Commission in connection with its review of the previously announced merger, in which Sanara will become a wholly-owned subsidiary of MiMedx. The Second Request extends the Hart-Scott-Rodino waiting period until 30 days after the parties substantially comply, unless extended voluntarily or terminated earlier by the FTC. Completion of the merger remains subject to HSR expiration or termination and other closing conditions in the Merger Agreement.
Source: SEC EDGAR, Form 8-K, Item 8.01, accession 0001213900-26-110053.
Written from the filing by Shamburg Markets. Figures are as reported by the company.